Influenza virus infection is an ongoing health and economic burden causing epidemics with
pandemic potential, affecting 5–30% of the global population annually, and is responsible …

Vaccines are recognized worldwide as one of the most important tools for combating
infectious diseases. Despite the tremendous value conferred by currently available vaccines …

Destructive impacts of COVID-19 pandemic worldwide necessitates taking more appropriate
measures for mitigating virus spread and development of the effective theranostic agents. In …

The concept of biomaterials has evolved from one of inert mechanical supports with a long‐
term, biologically inactive role in the body into complex matrices that exhibit selective cell …

Bacteriophage therapy dates back almost a century, but the discovery of antibiotics led to a
rapid decline in the interests and investments within this field of research. Recently, the …

Objective The recent availability of novel antiviral drugs has raised new hope for a more
effective treatment of hepatitis C virus (HCV) infection and its severe sequelae. However, in …

Computationally optimized broadly reactive Ags (COBRA) targeting H1 elicit a broad cross-
reactive and cross-neutralizing Ab response against multiple H1N1 viral strains. To assess B …

Pig‐to‐human xenotransplantation offers a potential bridge to the growing disparity between
patients with end‐stage organ failure and graft availability. Early studies attempting to …

Identification of B-cell epitopes in target antigens is one of the most crucial steps for
epitopebased vaccine development, immunodiagnostic tests, antibody production, and …

Infectious diseases (ID) are serious threats against the global health and socio-economic
conditions. Vaccination usually plays a key role in disease prevention, however, insufficient …